GO:0009235 cobalamin metabolic process: Vitamin B12 Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009235 cobalamin metabolic process describes all chemical reactions and pathways involving cobalamin (vitamin B12), a water-soluble corrinoid containing a central cobalt atom.
• Cobalamin metabolism depends on a network of multi-protein complexes for uptake, intracellular transport, and conversion into the active cofactors adenosylcobalamin and methylcobalamin [2,5].
• Key enzymes include MMUT, MTR, MTRR, LMBRD1, ABCD4, and CUBN, which are essential for mitochondrial and cytosolic cobalamin utilization [2,4].
• Defects in cobalamin metabolism cause remethylation disorders, megaloblastic anemia, and neurological dysfunction, often with elevated or low serum B12 [1,3,4].
• Cobalamin derivatives also participate in reductive dehalogenation and redox catalysis, expanding their biochemical roles beyond classical cofactor functions [6,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect cobalamin metabolic gene function and disease mechanisms [2,4].
Description
Cobalamin, also known as vitamin B12, is a water-soluble vitamin characterized by a corrin nucleus containing a cobalt atom. The Gene Ontology term GO:0009235, cobalamin metabolic process, encompasses the chemical reactions and pathways involving this essential micronutrient. Researchers study this process because cobalamin is a cofactor for methionine synthase and methylmalonyl-CoA mutase, and its metabolism intersects with folate cycling, mitochondrial energy production, and gene regulation [2,3]. Disruptions in cobalamin metabolism lead to a spectrum of disorders, from megaloblastic anemia to severe neurological impairment, making it a critical area of biomedical research [1,3,4]. The process involves a complex network of transport proteins, enzymes, and chaperones that ensure cobalamin is absorbed, distributed, and converted into its active forms [2,5]. Recent advances have revealed that cobalamin metabolism is not limited to classical cofactor roles but also includes redox-catalytic and reductive dehalogenation activities [6,8]. Understanding these pathways at the molecular level is essential for developing targeted therapies and diagnostic tools.
cobalamin metabolic process At A Glance
| GO ID | GO:0009235 |
|---|---|
| GO term | cobalamin metabolic process |
| Ontology | biological_process |
| Synonym | cobalamin metabolism; vitamin B12 metabolic process; vitamin B12 metabolism; vitamin B12 reduction |
| Major function | Uptake, transport, and enzymatic conversion of cobalamin into active cofactors adenosylcobalamin and methylcobalamin |
| Key enzymes | MMUT, MTR, MTRR, LMBRD1, ABCD4, CUBN, TCN1, TCN2 |
| Associated diseases | Remethylation disorders, megaloblastic anemia, neurological dysfunction, methylmalonic aciduria |
| Subcellular locations | Mitochondria, cytosol, lysosome, plasma membrane |
What Is GO:0009235?
GO:0009235 cobalamin metabolic process is defined as the chemical reactions and pathways involving cobalamin (vitamin B12), a water-soluble vitamin characterized by possession of a corrin nucleus containing a cobalt atom. This includes the synthesis, transport, modification, and utilization of cobalamin and its derivatives within cells.
Why Is cobalamin metabolic process Important in Cell Biology?
Cobalamin metabolic process is vital because cobalamin is an essential cofactor for methionine synthase and methylmalonyl-CoA mutase, which are required for DNA synthesis, amino acid metabolism, and mitochondrial energy production [2,3]. Defects in this pathway cause a range of clinical disorders, including remethylation disorders, megaloblastic anemia, and neurological degeneration, often with elevated or low serum cobalamin levels [1,3,4]. Studying cobalamin metabolism provides insights into vitamin transport, enzyme catalysis, and the interplay between nutrition and genetics, and it informs the development of biomarkers and therapies for related diseases [2,4].
• Cobalamin is a cofactor for methionine synthase (MTR) and methylmalonyl-CoA mutase (MMUT), linking it to one-carbon metabolism and mitochondrial energy production [2,3].
• Defects in cobalamin metabolism cause remethylation disorders, which can present with hyperhomocysteinemia and neurological symptoms.
• Elevated serum cobalamin levels can be a marker of underlying malignancies or liver disease, making cobalamin metabolism clinically relevant.
• Cobalamin deficiency leads to megaloblastic anemia and irreversible neurological damage if untreated.
• Membrane transport of cobalamin involves specific receptors and transporters, such as CUBN and TCN2, which are critical for cellular uptake.
• Cobalamin derivatives exhibit redox-catalytic properties that expand their biochemical roles beyond classical cofactor functions.
• Food-cobalamin malabsorption syndrome is a common cause of deficiency, particularly in the elderly.
• Cobalamin-dependent reductive dehalogenation is important in microbial catabolism and bioremediation.
• Genetic variants in cobalamin metabolism genes influence susceptibility to rare and common diseases [2,4].
• CRISPR-based models enable precise dissection of cobalamin metabolic pathways and disease mechanisms [2,4].
What Happens During cobalamin metabolic process?
Cobalamin uptake and transport
In simple terms: The body must capture vitamin B12 from food and move it into cells.
Cobalamin is released from food proteins in the stomach and binds to haptocorrin (TCN1) or intrinsic factor. In the intestine, the cubilin-amnionless receptor complex (CUBN) mediates uptake of the intrinsic factor-cobalamin complex. Inside cells, cobalamin is transported by transcobalamin II (TCN2) and delivered to lysosomes, where it is released by the action of LMBRD1 and ABCD4 [2,5].
Intracellular processing and cofactor synthesis
In simple terms: Once inside, vitamin B12 is converted into its two active forms.
In the cytosol, cobalamin is reduced and converted to methylcobalamin, which is required for methionine synthase (MTR) activity. In mitochondria, it is converted to adenosylcobalamin, the cofactor for methylmalonyl-CoA mutase (MMUT). These conversions involve multiple proteins, including MTRR, which regenerates methylcobalamin [2,4].
Methionine synthase and one-carbon metabolism
In simple terms: Vitamin B12 helps recycle methionine, which is needed for DNA and protein methylation.
Methylcobalamin serves as a cofactor for MTR, which catalyzes the conversion of homocysteine to methionine. This reaction is coupled to folate metabolism and is essential for the synthesis of S-adenosylmethionine, the primary methyl donor for DNA and protein methylation [2,3]. Defects in this pathway lead to hyperhomocysteinemia and remethylation disorders.
Mitochondrial cobalamin metabolism and energy production
In simple terms: Vitamin B12 also helps break down certain fats and amino acids in mitochondria.
Adenosylcobalamin is required for MMUT, which converts methylmalonyl-CoA to succinyl-CoA, an intermediate in the TCA cycle. This pathway links cobalamin metabolism to mitochondrial energy production and is disrupted in methylmalonic aciduria [2,3].
Redox-catalytic and reductive dehalogenation roles
In simple terms: Vitamin B12 can also participate in chemical reactions that remove halogens from molecules.
Cobalamins exhibit redox-catalytic properties and can act as electron carriers in reductive dehalogenation reactions, which are important in microbial catabolism and bioremediation [6,8]. These activities expand the biochemical repertoire of cobalamin beyond its classical cofactor functions [6,8].
Key Genes Involved in GO:0009235 cobalamin metabolic process
The following genes and proteins are central to cobalamin metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MMUT | Mitochondrial methylmalonyl-CoA mutase; uses adenosylcobalamin to convert methylmalonyl-CoA to succinyl-CoA | Mutations cause methylmalonic aciduria; target for metabolic studies [2,3] |
| MTR | Methionine synthase; uses methylcobalamin to convert homocysteine to methionine | Defects cause remethylation disorders; key for one-carbon metabolism [2,4] |
| MTRR | Methionine synthase reductase; regenerates methylcobalamin for MTR | Mutations lead to functional MTR deficiency; studied in remethylation disorders [2,4] |
| LMBRD1 | Lysosomal cobalamin transport protein; facilitates cobalamin release from lysosomes | Defects cause cblF complementation group of cobalamin disorders [2,5] |
| ABCD4 | Lysosomal ATP-binding cassette transporter; exports cobalamin from lysosomes | Mutations cause cblJ disorder; studied in intracellular transport [2,5] |
| CUBN | Cubilin; receptor for intrinsic factor-cobalamin complex in intestine | Defects cause Imerslund-Gräsbeck syndrome; target for uptake studies |
| TCN1 | Haptocorrin; binds cobalamin in saliva and stomach | Involved in food-cobalamin absorption; biomarker for deficiency [5,7] |
| TCN2 | Transcobalamin II; transports cobalamin in blood and delivers to cells | Deficiency causes severe early-onset cobalamin disorder |
| AMN | Amnionless; part of cubilin receptor complex | Mutations cause Imerslund-Gräsbeck syndrome |
| FUT2 | Fucosyltransferase 2; affects cobalamin absorption via intestinal glycosylation | Genetic modifier of cobalamin status |
| CD320 | Transcobalamin receptor; mediates cellular uptake of TCN2-cobalamin | Regulates cobalamin delivery to tissues |
| MMAA | Methylmalonic aciduria type A protein; protects MMUT and facilitates adenosylcobalamin loading | Mutations cause methylmalonic aciduria; chaperone-like function |
| MMAB | Methylmalonic aciduria type B protein; catalyzes adenosylcobalamin synthesis | Defects cause methylmalonic aciduria; mitochondrial enzyme |
| MMADHC | Methylmalonic aciduria and homocystinuria type D protein; directs cobalamin to mitochondrial or cytosolic pathways | Mutations cause combined remethylation and methylmalonic aciduria [2,4] |
| MTHFR | Methylenetetrahydrofolate reductase; links folate and cobalamin metabolism | Polymorphisms affect homocysteine levels and disease risk [3,4] |
| CBS | Cystathionine beta-synthase; transsulfuration pathway enzyme | Interacts with cobalamin metabolism in homocysteine regulation |
| SLC46A1 | Proton-coupled folate transporter; may influence cobalamin absorption | Studied in intestinal transport |
| GIF | Gastric intrinsic factor; essential for cobalamin absorption in ileum | Deficiency causes pernicious anemia [5,7] |
How Is cobalamin metabolic process Regulated?
Cobalamin metabolic process is regulated at multiple levels. Transcriptional regulation of genes such as MTR, MTRR, and MMUT responds to cellular demands for methionine and succinyl-CoA. Post-translational modifications and protein-protein interactions control the assembly of cobalamin-dependent enzymes and their chaperones, such as MMAA and MMAB. Intracellular cobalamin trafficking is regulated by lysosomal transporters LMBRD1 and ABCD4, which respond to cobalamin availability. Additionally, the redox state of the cell influences the interconversion of cobalamin forms, affecting cofactor availability. Hormonal and nutritional factors, including vitamin B12 intake and folate status, also modulate pathway activity [3,7].
cobalamin metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTR | Remethylation disorder, hyperhomocysteinemia | Knockout or point-mutation cell lines; patient-derived fibroblasts |
| MMUT | Methylmalonic aciduria | Knockout HEK293 or HepG2 cells; mitochondrial function assays |
| LMBRD1 | CblF disorder, lysosomal cobalamin accumulation | Knockout HeLa cells; lysosomal trafficking studies [2,5] |
| CUBN | Imerslund-Gräsbeck syndrome | Knockout intestinal epithelial cells; uptake assays |
| TCN2 | Transcobalamin II deficiency | Knockout hepatocytes; secretion and transport studies |
Remethylation disorders and neurological dysfunction
Remethylation disorders are a group of inherited conditions caused by defects in cobalamin metabolism, particularly in the cytosolic pathway involving MTR and MTRR. Patients present with hyperhomocysteinemia, hypomethioninemia, and neurological symptoms such as developmental delay, seizures, and cognitive decline. Early diagnosis and treatment with cobalamin, betaine, and folate can improve outcomes, but delayed treatment may lead to irreversible damage.
Methylmalonic aciduria and mitochondrial dysfunction
Mutations in MMUT, MMAA, MMAB, or MMADHC cause methylmalonic aciduria, characterized by accumulation of methylmalonic acid and mitochondrial dysfunction [2,3]. Clinical features include lethargy, vomiting, metabolic acidosis, and long-term complications such as renal failure and neurological impairment. Adenosylcobalamin supplementation can be therapeutic for some forms, but not for all.
Cobalamin deficiency and elevated serum B12
Cobalamin deficiency, often due to malabsorption or dietary insufficiency, leads to megaloblastic anemia and neurological deficits. Food-cobalamin malabsorption syndrome is a common cause in the elderly. Conversely, elevated serum cobalamin levels can be a marker of underlying malignancies, liver disease, or myeloproliferative disorders, and may indicate altered cobalamin metabolism.
Cobalamin in cancer and redox biology
Altered cobalamin metabolism has been observed in cancer, where elevated serum B12 may reflect increased turnover or tumor-related changes. Cobalamin derivatives also exhibit redox-catalytic properties that can influence oxidative stress and cellular signaling. These findings suggest that cobalamin metabolism intersects with cancer biology and redox regulation [1,6].
From cobalamin metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MTR affect methionine synthesis? | MTR knockout HAP1 or HEK293 cells [2,4] |
| How do point mutations in MMUT alter enzyme activity? | MMUT point-mutation knock-in cell lines |
| What is the role of LMBRD1 in lysosomal cobalamin export? | LMBRD1 knockout HeLa cells with tagged cobalamin [2,5] |
| Can overexpression of MTRR rescue MTR function? | MTRR overexpression in patient fibroblasts |
| How does CUBN mediate cobalamin uptake? | CUBN knockout Caco-2 cells |
| Does MMAA chaperone function require ATP? | MMAA tagged knock-in cells; proteomics |
How to Study the cobalamin metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression levels | Transcriptional profiling of cobalamin metabolism genes |
| Whole-exome sequencing | Genetic variants | Diagnosis of remethylation disorders |
| LC-MS/MS metabolomics | Cobalamin derivatives, homocysteine, methionine | Functional assessment of pathway activity [2,3] |
| Enzyme activity assay | MTR and MMUT catalytic activity | Characterization of mutant enzymes |
| Fluorescence microscopy | Subcellular localization of cobalamin | Lysosomal trafficking studies |
| CRISPR knockout screening | Gene essentiality and pathway dependencies | Identification of novel cobalamin regulators |
| Proteomics | Protein-protein interactions | Assembly of cobalamin metabolic complexes |
| Patient-derived fibroblasts | Cellular phenotype | Diagnosis and drug testing |
Genomic and transcriptomic profiling
RNA-seq and whole-exome sequencing can identify variants in cobalamin metabolism genes and quantify their expression [2,4]. These methods are used to discover novel disease-causing mutations and to study transcriptional regulation.
Proteomics and metabolomics
Mass spectrometry-based proteomics can measure protein levels and interactions within cobalamin metabolic complexes. Metabolomics quantifies cobalamin derivatives, homocysteine, methionine, and methylmalonic acid, providing functional readouts [2,3].
Enzymatic activity assays
Methionine synthase and methylmalonyl-CoA mutase activities can be measured in cell lysates using radiolabeled substrates or coupled assays. These assays are used to assess the impact of mutations and to screen for therapeutic compounds.
Imaging and subcellular localization
Fluorescence microscopy with tagged cobalamin or fluorescently labeled proteins can track cobalamin trafficking in live cells. This approach reveals lysosomal export defects and mitochondrial targeting.
How CRISPR Can Be Used to Study GO:0009235 cobalamin metabolic process
Knockout
CRISPR knockout of genes such as MTR, MMUT, or LMBRD1 in cell lines can model loss-of-function and reveal their roles in cobalamin metabolism [2,4]. Knockout cells are used to study metabolic dependencies and to validate drug targets.
Point Mutation
Point mutations identified in patients can be introduced into cell lines using CRISPR base editing or homology-directed repair to study their functional impact [2,4]. This approach helps distinguish pathogenic variants from benign polymorphisms.
Knock-in
Knock-in of tagged cobalamin metabolism proteins, such as GFP-tagged LMBRD1, allows real-time tracking of protein localization and interactions. Knock-in of disease-associated alleles can create isogenic models for drug testing.
Overexpression
Overexpression of genes like MTRR or TCN2 can rescue deficiency phenotypes or amplify pathway activity for biochemical studies [2,4]. Overexpression models are useful for producing recombinant proteins and for screening inhibitors.
How EDITGENE Supports cobalamin metabolic process Research
Researchers studying cobalamin metabolic process-related genes often need to determine whether a candidate gene is causally involved in disease or pathway regulation. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for cobalamin metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MMACHC Knockout HEK293 Cell Line | EDC07667 | Human | 25974 | Details Get a Quote |
| MMAA Knockout HEK293 Cell Line | EDJ-KQ2903 | Human | 166785 | Details Get a Quote |
| MTR Knockout HEK293 Cell Line | EDJ-KQ5268 | Human | 4548 | Details Get a Quote |
| MTRR Knockout HEK293 Cell Line | EDJ-KQ5269 | Human | 4552 | Details Get a Quote |
| ABCD4 Knockout HEK293 Cell Line | EDJ-KQ5612 | Human | 5826 | Details Get a Quote |
| CUBN Knockout HEK293 Cell Line | EDJ-KQ6160 | Human | 8029 | Details Get a Quote |
| MMADHC Knockout HEK293 Cell Line | EDJ-KQ8735 | Human | 27249 | Details Get a Quote |
| AMN Knockout HEK293 Cell Line | EDJ-KQ9741 | Human | 81693 | Details Get a Quote |
| MMAB Knockout HEK293 Cell Line | EDJ-KQ12051 | Human | 326625 | Details Get a Quote |
| MTR Knockout A-549 Cell Line | EDJ-KQ27076 | Human | 4548 | Details Get a Quote |
| MMADHC Knockout A-549 Cell Line | EDJ-KQ34978 | Human | 27249 | Details Get a Quote |
| MMADHC Knockout HCT 116 Cell Line | EDJ-KQ34979 | Human | 27249 | Details Get a Quote |
| MMADHC Knockout HeLa Cell Line | EDJ-KQ34980 | Human | 27249 | Details Get a Quote |
| MMACHC Knockout A-549 Cell Line | EDJ-KQ24227 | Human | 25974 | Details Get a Quote |
| MMACHC Knockout HCT 116 Cell Line | EDJ-KQ24228 | Human | 25974 | Details Get a Quote |
Displaying Records 1 To 15 Of 39 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About cobalamin metabolic process
What is cobalamin metabolic process?
Cobalamin metabolic process (GO:0009235) encompasses all chemical reactions and pathways involving cobalamin (vitamin B12), including its uptake, transport, and conversion into active cofactors.
What genes are involved in cobalamin metabolic process?
Key genes include MMUT, MTR, MTRR, LMBRD1, ABCD4, CUBN, TCN1, TCN2, and MMAA, among others [2,5].
What diseases are associated with defects in cobalamin metabolism?
Defects cause remethylation disorders, methylmalonic aciduria, megaloblastic anemia, and neurological dysfunction [2,3,4].
How is cobalamin transported into cells?
Cobalamin is transported by transcobalamin II (TCN2) and taken up via the CD320 receptor; in the intestine, the cubilin-amnionless complex mediates absorption.
What are the active forms of cobalamin?
The two active cofactors are methylcobalamin, used by methionine synthase, and adenosylcobalamin, used by methylmalonyl-CoA mutase.
Can CRISPR be used to study cobalamin metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect cobalamin metabolic pathways and disease mechanisms [2,4].
What is the role of MTR in cobalamin metabolism?
MTR (methionine synthase) uses methylcobalamin to convert homocysteine to methionine, linking cobalamin to one-carbon metabolism [2,3].
What is methylmalonic aciduria?
Methylmalonic aciduria is a disorder caused by mutations in MMUT, MMAA, MMAB, or MMADHC, leading to accumulation of methylmalonic acid and mitochondrial dysfunction [2,3].
How is cobalamin deficiency diagnosed?
Diagnosis involves measuring serum cobalamin, homocysteine, and methylmalonic acid levels, along with genetic testing for remethylation disorders [3,4].
What research methods are used to study cobalamin metabolism?
Common methods include RNA-seq, metabolomics, enzyme activity assays, fluorescence microscopy, and CRISPR screening [2,5].
Conclusion
Cobalamin metabolic process (GO:0009235) is a fundamental biological pathway that governs the uptake, transport, and utilization of vitamin B12. Its importance spans one-carbon metabolism, mitochondrial energy production, and redox biology, with defects leading to severe diseases such as remethylation disorders and methylmalonic aciduria [2,3,4]. Advances in CRISPR-based models and multi-omics technologies are accelerating the discovery of novel regulators and therapeutic targets [2,4]. Continued research into cobalamin metabolism will improve diagnosis and treatment for affected patients and deepen our understanding of vitamin B12 biology [1,5].
References
- 1. Ermens AA et al.. 2003. Significance of elevated cobalamin (vitamin B12) levels in blood.. Clin Biochem 36(8):585-90 PMID: 14636871
- 2. Mucha P et al.. 2024. Vitamin B(12) Metabolism: A Network of Multi-Protein Mediated Processes.. Int J Mol Sci 25(15) PMID: 39125597
- 3. Herrmann W et al.. 2012. Cobalamin deficiency.. Subcell Biochem 56:301-22 PMID: 22116706
- 4. Olivieri G et al.. 2026. First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.. J Inherit Metab Dis 49(4):e70177 PMID: 42231716
- 5. Nijland M et al.. 2022. Membrane transport of cobalamin.. Vitam Horm 119:121-148 PMID: 35337617
- 6. Shatalin YV et al.. 2023. [The Redox-Catalytic Properties of Cobalamins].. Mol Biol (Mosk) 57(6):1043-1057 PMID: 38062959
- 7. Serraj K et al.. 2009. [Food-cobalamin syndrome].. Presse Med 38(1):55-62 PMID: 18990540
- 8. Fincker M et al.. 2017. Biochemistry of Catabolic Reductive Dehalogenation.. Annu Rev Biochem 86:357-386 PMID: 28654328
